MENU
PVLA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Palvella Therapeutics (PVLA) Earnings Date & Reports
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies... Show more
A.I. Advisor
published Earnings
PVLA is expected to report earnings to rise 18.42% to -179 cents per share on November 17
Q3'26
Est.
$-1.80
Q2'26
Missed
by $0.36
Q1'26
Missed
by $0.71
Q4'25
Beat
by $0.04
Q3'25
Beat
by $1.10
The last earnings report on August 04 showed earnings per share of -151 cents, missing the estimate of -115 cents. With 131.89K shares outstanding, the current market capitalization sits at 1.77B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
What is Operating Leverage?
What is a Coverdell ESA?
What are the IRS Guidelines for Filing a Form 4868 Tax Return Extension?
What are seven effective strategies for quickly generating cash?
Anti-Bubble ETF Playbook: Leveraged Traps & Hidden Value Refuges as AI Semiconductors Trade at 2× the Dot-Com Peak
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
353 W. Lancaster Avenue
Phone
+1 484 253-1461
Employees
29
Web
https://www.palvellatx.com